Applications

SequiDose is intended for hospital and clinical use, particularly in emergency departments, critical care units, surgical suites, and long-term care. It simplifies IV drug delivery, improves safety, and streamlines workflows where rapid and aseptic administration is critical.

Target Problems

IV drug administration is essential in healthcare but poses safety risks, including central line-associated bloodstream infections and medication errors. Frequent line access also increases infection risk and introduces the chance of dosing errors, drug incompatibilities, and environmental waste. Current prefilled syringes reduce some complexity but still require multiple manipulations, compromising aseptic technique.

Solution

Pre-filled syringe system for sequential drug and flush delivery: SequiDose™

Key Benefits

• Enables sequential delivery of multiple, pre-measured medications or flushes
• Minimizes IV-line manipulations and reduces infection risk
• Streamlines workflow—reduces syringe swaps
• Supports consistent, aseptic delivery in high-pressure clinical settings
• Decreases medication errors by ensuring accurate dosing
• Compatible with existing IV administration protocols

Stage of Development

Initial design and prototyping have resulted in a rough working syringe and pods. Additional work is needed to test the feasibility of this system.

Partnering Opportunity

SequiDose LLC has an exclusive option agreement with the UWM Research Foundation to evaluate this technology for licensing. Together, the parties are working to find additional partners to develop the technology into a final product.

Intellectual Property

Non-provisional patent application filed spring 2025.

Inventor(s)

Jessica Rotier, PhD, MSN/Ed, RN, CHSE, CNE, CNL
Clinical Associate Professor, Nursing

Osvaldo Sepulveda, PhD